Table 1.

Screen-detected type-specific hrHPV incidence

POBASCAMNTCC
(n = 16,671)(n = 7,434)
hrHPV (%)426 (2.54)233 (3.13)
HPV16 (%)117 (0.7)67 (0.9)
HPV18 (%)41 (0.25)28 (0.38)
HPV31 (%)48 (0.29)37 (0.5)
HPV33 (%)27 (0.16)8 (0.11)
HPV35 (%)24 (0.14)4 (0.05)
HPV39 (%)22 (0.13)16 (0.22)
HPV45 (%)41 (0.25)14 (0.19)
HPV51 (%)48 (0.29)31 (0.42)
HPV52 (%)43 (0.26)16 (0.22)
HPV56 (%)42 (0.25)20 (0.27)
HPV58 (%)22 (0.13)14 (0.19)
HPV59 (%)17 (0.1)14 (0.19)
HPV68 (%)5 (0.03)15 (0.2)

NOTE: Screenings interval POBASCAM 5 years; NTCC 3 years.